Nonalcoholic fatty liver disease (NAFLD) is estimated to afflict approximately 1 billion
individuals worldwide. In a subset of NAFLD patients, who have the progressive form of …

Objective To quantify the association of indices of central obesity, including waist
circumference, hip circumference, thigh circumference, waist-to-hip ratio, waist-to-height …

Non-invasive tests are increasingly being used to improve the diagnosis and
prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest …

Background & Aims Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic
steatohepatitis (NASH) are increasingly a cause of cirrhosis and hepatocellular carcinoma …

Nonalcoholic fatty liver disease (NAFLD) affects 25% of the global adult population and is
the most common chronic liver disease worldwide. Nonalcoholic steatohepatitis (NASH) is …

The Clinical Practice Guidelines (CPG) propose recommendations for the diagnosis,
treatment and follow-up of non-alcoholic fatty liver disease (NAFLD) patients and are the …

Background The liver is a key regulator of systemic energy homeostasis and can sense and
respond to nutrient excess and deficiency through crosstalk with multiple tissues. Regulation …

To survey the burden of liver disease in Europe and its causes 260 epidemiological studies
published in the last five years were reviewed. The incidence and prevalence of cirrhosis …

It is estimated that 30% of the adult population in Japan is affected by nonalcoholic fatty liver
disease (NAFLD). Fatty changes of the liver are generally diagnosed using imaging …

Background Several steatosis biomarkers are available with limited independent validation.
Aim To determine diagnostic value and limitations of several steatosis biomarkers using liver …